Versant Capital Management, Inc Rigel Pharmaceuticals Inc Transaction History
Versant Capital Management, Inc
- $710 Million
- Q3 2025
A detailed history of Versant Capital Management, Inc transactions in Rigel Pharmaceuticals Inc stock. As of the latest transaction made, Versant Capital Management, Inc holds 224 shares of RIGL stock, worth $9,414. This represents 0.0% of its overall portfolio holdings.
Number of Shares
224
Previous 225
0.44%
Holding current value
$9,414
Previous $4,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding RIGL
# of Institutions
9Shares Held
365KCall Options Held
0Put Options Held
0-
Telemetry Investments, L.L.C. New York, NY323KShares$13.6 Million0.76% of portfolio
-
Advisory Services Network, LLC31.7KShares$1.33 Million0.01% of portfolio
-
Bergan Kdv Wealth Management, LLC10KShares$420,3000.0% of portfolio
-
Farther Finance Advisors, LLC San Francisco, CA730Shares$30,6810.0% of portfolio
-
Lri Investments, LLC Palm Beach Gardens, FL124Shares$5,2110.0% of portfolio
About RIGEL PHARMACEUTICALS INC
- Ticker RIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 172,836,000
- Market Cap $7.26B
- Description
- Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...